# Larimar Therapeutics, Inc.: Form SC 13D, filed Jun 8, 2020

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: SC 13D
- Filed: 2020-06-08
- Accepted by EDGAR: Jun 8, 2020, 17:10 ET
- Period: not reported
- Accession: 0001193805-20-000670
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119380520000670/e619689_sc13d-lt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119380520000670/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119380520000670/e619689_sc13d-lt.htm

Filed Jun 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001193805-20-000670. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
